Viewing Study NCT06456567


Ignite Creation Date: 2025-12-25 @ 12:38 AM
Ignite Modification Date: 2026-01-06 @ 2:15 PM
Study NCT ID: NCT06456567
Status: RECRUITING
Last Update Posted: 2024-09-19
First Post: 2024-06-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-2)
Sponsor: RemeGen Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module